SC Filed 2023-10-11 Event — SEC 0001013762-23-003194 →

Vivo Opportunity Fund Holdings, L.P. → SOLENO THERAPEUTICS INC SLNO

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

12 13D/G filings on this issuer

11 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-05-15

DTC 2.31

4,405,832 shares short · -32.5% vs prior

Other 13D/G Filings on SOLENO THERAPEUTICS INC

Filed	Form	Filer	Stake	Shares
2024-10-15	SC	Carlyle Group Inc.	—	—	view →
2023-10-03	SC	Carlyle Group Inc.	—	—	view →
2023-06-06	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2023-05-30	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2023-05-25	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2020-07-17	SC	Jack W. Schuler Living Trust	—	—	view →
2020-07-06	SC	Abingworth LLP	—	—	view →
2020-06-11	SC	Vivo Ventures V, LLC	—	—	view →
2019-12-09	SC	Vivo Ventures V, LLC	—	—	view →
2019-01-15	SC	BIOASIA MANGEMENT LLC	—	—	view →
2019-01-03	SC	Jack W. Schuler Living Trust	—	—	view →

Other Filings by Vivo Opportunity Fund Holdings, L.P.

Filed	Form	Issuer	Stake	Shares
2026-10-13	SCHEDULE 13G	ArriVent BioPharma, Inc.	—	—	view →
2026-07-08	SCHEDULE 13G	Achieve Life Sciences, Inc. ACHV	—	—	view →
2026-06-10	SCHEDULE 13D	InMed Pharmaceuticals Inc. INM	21.70%	718,444	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →